From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Aydin Harston <aharston@rothwellfigg.com>
`Wednesday, August 23, 2017 1:55 PM
`Hartmann, Anthony
`E. Anthony Figg; LITIGATION PARALEGALS; Livingstone, John; Yoshida, Naoki;
`toan.vo@bausch.com
`RE: ACRUX DDS PTY LTD. & ACRUX LIMITED v. KAKEN PHARMACEUTICAL CO., LTD.
`Case IPR2017-00190
`
`Dear Tony, 
`
`  
`As you suggested on our call yesterday, we are reviewing the supplemental evidence that Patent Owner served last 
`night to determine whether our concerns have been addressed.  When we have completed that review, I will follow up 
`with you if necessary. 
`
`  
`Best, 
`Aydin 
`
`  
`Aydin H. Harston, Ph.D. 
`Rothwell, Figg, Ernst & Manbeck PC 
`607 14th Street, NW; Suite 800 
`Washington, DC 20005 
`ph: 202-783-6040 
`fax: 202-783-6031 
`www.rfem.com 
`
` 
`The information contained in this electronic message and any attachments to this message are intended for the exclusive use of the addressee(s) and
`may contain confidential and/or privileged information. If you are not the addressee, note that any disclosure, copy, distribution or use of the contents of
`this message is prohibited. If you are not the intended recipient, please notify Rothwell, Figg, Ernst & Manbeck P.C. immediately at (202) 783-6040 or
`email us at aharston@rfem.com, and destroy all copies of this message and any attachments. 
`   
`  
`
`  
`From: Hartmann, Anthony [mailto:anthony.hartmann@finnegan.com]
`Sent: Wednesday, August 23, 2017 1:13 PM
`To: Aydin Harston
`Cc: E. Anthony Figg; LITIGATION PARALEGALS; Livingstone, John; Yoshida, Naoki; toan.vo@bausch.com
`Subject: ACRUX DDS PTY LTD. & ACRUX LIMITED v. KAKEN PHARMACEUTICAL CO., LTD. Case IPR2017-00190 
`
`  
`Dear Aydin, 
`
`  
`Further to our conversation of yesterday, we do not understand what additional discovery you are seeking, for which 
`you sought a meet and confer.  During the call, you did not provide us with a clear understanding of the full scope of the 
`discovery that Acrux seeks.  Once we have a clear understanding of your request for discovery, we can then consult with 
`our clients on this matter before any meet and confer.   
`
`  
`We look forward to obtaining some clarification from you. 
`
`  
`Regards, 
`Tony 
`Counsel for Patent Owner 
`
`1
`
`

`

`  
`
`Anthony A. Hartmann
`Of Counsel
`Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`901 New York Avenue, NW, Washington, DC 20001-4413
`+1 202 408 4275 | fax +1 202 408 4400 | anthony.hartmann@finnegan.com | www.finnegan.com 
`
` 
`
`  
`
`
`This e-mail message is intended only for individual(s) to whom it is addressed and may contain information that is privileged, confidential, proprietary, or otherwise
`exempt from disclosure under applicable law. If you believe you have received this message in error, please advise the sender by return e-mail and delete it from
`your mailbox. Thank you. 
`
`2
`
`